Results 81 to 90 of about 32,738 (290)

The role of cytokines in ovarian cancer drug resistance

International Journal of Cancer, Volume 158, Issue 4, Page 821-834, 15 February 2026.
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang, Yunxia Zang, Rebeka Dejenie, Junyuan Bing, Shixia Dong, Yanfei Zhang, Yi Zhu, Jingjing Li   +7 more
wiley   +1 more source

A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—case report

World Journal of Surgical Oncology, 2020
Background Anal cancer is a rare cancer with chemoradiation being the mainstay of treatment for locoregional presentation. In North America, the most common subtype is anal squamous cell carcinoma (epidermoid).
Vera Pravong, Alexandre Brind’Amour, Lucas Sidéris, Pierre Dubé, Jean-François Tremblay   +4 more
doaj   +1 more source

Prognostic Factors and Nomogram‐Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Colorectal cancer (CRC) with synchronous peritoneal metastasis (SPM) presents poor prognosis and complex treatment challenges. This study aimed to identify independent prognostic factors and develop nomogram‐based prediction models for overall survival (OS) and progression‐free survival (PFS) in CRC patients with SPM (CRC‐SPM ...
Xiaoxu Ge, Guanli Yang, Huiming Wu, Lei Liu, Ming Zhou, Akao Zhu, Xiangxing Kong, Jingjing Wu, Yeting Hu, Kefeng Ding, Lifeng Sun, Jian Wang   +11 more
wiley   +1 more source

Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol [PDF]

, 2022
Rayan Taher, Sophia Stanford, Norman J. Carr, Nancy Vanderpuye, Kandiah Chandrakumaran   +4 more
openalex   +1 more source

Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]

Annals of Coloproctology, 2017
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety and oncological benefits are subjects of debate.
Kim, Woo Ram, Hur, Hyuk, Min, Byung Soh, Baik, Seung Hyuk, Lee, Kang Young, Kim, Nam Kyu   +5 more
openaire   +3 more sources

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy

World Journal of Surgical Oncology, 2021
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are effective routine treatments for colorectal peritoneal metastasis (PM).
Sicheng Zhou, Yujuan Jiang, Jianwei Liang, W. Pei, Zhixiang Zhou   +4 more
semanticscholar   +1 more source

Prospective case‐control cohort analysis of two‐day/two‐stage pelvic exenteration surgery: Safety, feasibility, acceptability and medium‐term outcomes

Colorectal Disease, Volume 28, Issue 1, January 2026.
Abstract Aim Pelvic exenteration (PE) is the only curative option for extensive pelvic cancers. Advances have facilitated increasingly complex resectional and reconstructive components, including per‐operative oncological adjuncts such as intraoperative radiotherapy.
Charles T. West, Yousif Salem, Siddharth Jain, Lewis Matthews, Julian Smith, Marios Nicolaou, Hideaki Yano, Malcolm A. West, Alex H. Mirnezami   +8 more
wiley   +1 more source

The Registry of Hyperthermic Intraperitoneal Chemotherapy – A Mandatory Step in the Development of this Therapeutic Approach in Romania

Applied Medical Informatics, 2015
Multicenter/institutional studies have been the basis for the confirmation of Hyperthermic Intraperitoneal Chemotherapy as a therapeutic option for selected patients with Peritoneal Surface Malignancies.
Corneliu LUNGOCI, Tudor CĂLINICI, Olga ORĂŞAN, Rareş BOSU, Valentin MUNTEAN, Aurel Ion MIRONIUC   +5 more
doaj  

Pediatric peri-operative fractionated high-dose-rate brachytherapy for recurrent Wilms’ tumor using a reconstructed Freiburg flap

Journal of Contemporary Brachytherapy, 2016
Purpose : To report peri-operative fractionated high-dose-rate (HDR) brachytherapy with a 3D customized Freiburg flap applicator to treat locally recurrent Wilms’ tumor, followed by immediate hyperthermic intraperitoneal chemotherapy for a 16-year-old ...
Emily Flower, Kathy Ngoc Tran, Salman Zanjani, Wayne Smith, Jonathan Karpelowsky, Katie Summerhayes, Edgar Estoesta, Jennifer Chard   +7 more
doaj   +1 more source

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Journal of Clinical Oncology, 2019
PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. Here we aimed to
P. Bonnot, G. Piessen, V. Kepenekian, E. Decullier, M. Pocard, B. Meunier, J. Bereder, K. Abboud, F. Marchal, F. Quénet, D. Goéré, S. Msika, C. Arvieux, N. Pirró, R. Wernert, P. Rat, J. Gagnière, J. Lefèvre, T. Courvoisier, R. Kianmanesh, D. Vaudoyer, M. Rivoire, P. Meeus, G. Passot, O. Glehen   +24 more
semanticscholar   +1 more source